DOMETUSS-G
- Product NDC
- 53809-250
- Requested package NDC
- 53809-250-04
- 11-digit product format
- 538090250
- Labeler code
- 53809
- Product ID
- 53809-250_dc4a9eb6-1eb6-46ed-b51d-ef80ec05e694
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DOMEL
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2019-11-11
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 200 mg/1; mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53809-250-01 | DOMETUSS-G | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 53809-250-04 | DOMETUSS-G | 4 in 1 BOTTLE | TABLET | 4 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53809-250 | DOMETUSS-G (GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE) TABLET [DOMEL] | 2 | Legacy NDC, 2 package rows | 20241208_19e06e4d-9efb-4059-a33d-4a89c3a2534c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53809-250-04 | 53809025004 | 4 TABLET in 1 BOTTLE (53809-250-04) | 4 tablet | 2019-11-11 | 0000-00-00 | No | No | Current |